Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression

Matrix metalloproteinases (MMPs), a group of zinc-dependent endopeptidases involved in the degradation of the extracellular matrix, play an important role in tissue remodeling associated with various physiological processes such as morphogenesis, angiogenesis, and tissue repair, as well as pathologi...

Full description

Bibliographic Details
Main Authors: Yixuan Gong, Uma D. Chippada-Venkata, William K. Oh
Format: Article
Language:English
Published: MDPI AG 2014-06-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/6/3/1298
_version_ 1797707668121452544
author Yixuan Gong
Uma D. Chippada-Venkata
William K. Oh
author_facet Yixuan Gong
Uma D. Chippada-Venkata
William K. Oh
author_sort Yixuan Gong
collection DOAJ
description Matrix metalloproteinases (MMPs), a group of zinc-dependent endopeptidases involved in the degradation of the extracellular matrix, play an important role in tissue remodeling associated with various physiological processes such as morphogenesis, angiogenesis, and tissue repair, as well as pathological processes including cirrhosis, arthritis and cancer. The MMPs are well established as mediators of tumor invasion and metastasis by breaking down connective tissue barriers. Although there has been a vast amount of literature on the role of MMPs in invasion, metastasis and angiogenesis of various cancers, the role of these endopeptidases in prostate cancer progression has not been systematically reviewed. This overview summarizes findings on the tissue and blood expression of MMPs, their function, regulation and prognostic implication in human prostate cancer, with a focus on MMP-2, -7, -9, MT1-MMP and tissue inhibitor of metalloproteinase 1 (TIMP-1). This review also summarizes the efficacy and failure of early-generation matrix metalloproteinase inhibitors (MMPIs) in the treatment of metastatic prostate cancer and highlights the lessons and challenges for next generation MMPIs.
first_indexed 2024-03-12T06:09:43Z
format Article
id doaj.art-852c52ada9764292adea3a4ebe7a164b
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T06:09:43Z
publishDate 2014-06-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-852c52ada9764292adea3a4ebe7a164b2023-09-03T03:07:49ZengMDPI AGCancers2072-66942014-06-01631298132710.3390/cancers6031298cancers6031298Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer ProgressionYixuan Gong0Uma D. Chippada-Venkata1William K. Oh2Division of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USADivision of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USADivision of Hematology and Medical Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USAMatrix metalloproteinases (MMPs), a group of zinc-dependent endopeptidases involved in the degradation of the extracellular matrix, play an important role in tissue remodeling associated with various physiological processes such as morphogenesis, angiogenesis, and tissue repair, as well as pathological processes including cirrhosis, arthritis and cancer. The MMPs are well established as mediators of tumor invasion and metastasis by breaking down connective tissue barriers. Although there has been a vast amount of literature on the role of MMPs in invasion, metastasis and angiogenesis of various cancers, the role of these endopeptidases in prostate cancer progression has not been systematically reviewed. This overview summarizes findings on the tissue and blood expression of MMPs, their function, regulation and prognostic implication in human prostate cancer, with a focus on MMP-2, -7, -9, MT1-MMP and tissue inhibitor of metalloproteinase 1 (TIMP-1). This review also summarizes the efficacy and failure of early-generation matrix metalloproteinase inhibitors (MMPIs) in the treatment of metastatic prostate cancer and highlights the lessons and challenges for next generation MMPIs.http://www.mdpi.com/2072-6694/6/3/1298MMPTIMPprostate cancer
spellingShingle Yixuan Gong
Uma D. Chippada-Venkata
William K. Oh
Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
Cancers
MMP
TIMP
prostate cancer
title Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
title_full Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
title_fullStr Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
title_full_unstemmed Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
title_short Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
title_sort roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression
topic MMP
TIMP
prostate cancer
url http://www.mdpi.com/2072-6694/6/3/1298
work_keys_str_mv AT yixuangong rolesofmatrixmetalloproteinasesandtheirnaturalinhibitorsinprostatecancerprogression
AT umadchippadavenkata rolesofmatrixmetalloproteinasesandtheirnaturalinhibitorsinprostatecancerprogression
AT williamkoh rolesofmatrixmetalloproteinasesandtheirnaturalinhibitorsinprostatecancerprogression